Literature DB >> 31686730

The Comparison of Iodine-Type and MnO2-Type Oxidation for Measuring the Levels of Urine Neopterin and Biopterin in Patients with Hyperphenylalaninemia: A Descriptive-Analytic Study in Iran.

Atena Askarizadeh1, Shohreh Khatami1, Soghra Rouhi Dehnabeh1.   

Abstract

Fresh urine sample is required for measurement of pterins in patients with hyperphenylalaninemia (HPA) for detection of tetrahydrobiopterin (BH4) coenzyme deficiency. The present study aimed to measure the levels of neopterin and biopterin in the urine of patients with HPA using manganese dioxide (MnO2) and iodine oxidation methods. The levels of neopterin and biopterin in the urine of 124 patients were measured using two methods of oxidation (MnO2 and iodine) and the results were statistically analyzed using correlation test, Roc-Curve and ANOVA in SPSS-20 software. The level of significant was determined to be P > 0.05. Patients age mean ± SD = 4.96 year, neopterin and biopterin mean ± SD in 124 patients were 2.75 mmol/molcr and 2.49 mmol/molcr. Correlation regression between two methods (iodine and MnO2 oxidation) was 0.99. There was no significant difference between the two oxidation methods (P > 0.05). The results of this study showed that MnO2 oxidation can be a suitable alternative method instead of iodine oxidation for measurement of urine neopterin, biopterin and diagnosis of BH4 deficiency. © Association of Clinical Biochemists of India 2018.

Entities:  

Keywords:  HPLC; Hyperphenylalaninemia; MnO2 oxidation; Neopterin

Year:  2018        PMID: 31686730      PMCID: PMC6801254          DOI: 10.1007/s12291-018-0777-3

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  25 in total

Review 1.  Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies.

Authors:  Nenad Blau; Julia B Hennermann; Ulrich Langenbeck; Uta Lichter-Konecki
Journal:  Mol Genet Metab       Date:  2011-08-26       Impact factor: 4.797

2.  PAH Mutation Analysis Consortium Database: a database for disease-producing and other allelic variation at the human PAH locus.

Authors:  L Hoang; S Byck; L Prevost; C R Scriver
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

3.  Diagnosis of variant forms of hyperphenylalaninemia using filter paper spots of urine.

Authors:  K Narisawa; H Hayakawa; N Arai; N Matsuo; T Tanaka; K Naritomi; K Tada
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

4.  High-performance liquid chromatography with column switching for the analysis of biogenic amine metabolites and pterins.

Authors:  A Niederwieser; W Staudenmann; E Wetzel
Journal:  J Chromatogr       Date:  1984-05-04

5.  [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].

Authors:  Waldemar Halota; Barbara Jaruga; Małgorzata Pawłowska
Journal:  Pol Merkur Lekarski       Date:  2002-08

6.  Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge.

Authors:  W B Hanley; H Demshar; M A Preston; A Borczyk; W E Schoonheyt; J T Clarke; A Feigenbaum
Journal:  Early Hum Dev       Date:  1997-01-03       Impact factor: 2.079

7.  Urinary neopterin as a new biochemical marker for the monitoring of disease activity and prognosis in membranous nephropathy associated with hepatitis B surface antigenemia.

Authors:  C Y Lin
Journal:  Nephron       Date:  1989       Impact factor: 2.847

8.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02

9.  The clinical significance of serum and urinary neopterin levels in several renal diseases.

Authors:  Hyun Young Lhee; Hyang Kim; Kwan Joong Joo; Soo Suk Jung; Kyu Beck Lee
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

10.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.